<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04615247</url>
  </required_header>
  <id_info>
    <org_study_id>19-29762</org_study_id>
    <secondary_id>R34AT010356</secondary_id>
    <nct_id>NCT04615247</nct_id>
  </id_info>
  <brief_title>Program to Overcome Pelvic Pain Study</brief_title>
  <acronym>POPPY</acronym>
  <official_title>A Feasibility Trial of a Group Based Yoga Intervention for Chronic Pelvic Pain in Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Center for Complementary and Integrative Health (NCCIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, San Francisco</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To refine and evaluate the feasibility of procedures for a future full-scale efficacy trial&#xD;
      of a group-based therapeutic yoga intervention versus physical conditioning (stretching and&#xD;
      strengthening) intervention for women with chronic pelvic pain.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 30, 2020</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">August 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of randomized participants who: a) are retained at 8 weeks, b) attend at least 75% of intervention classes, c) demonstrate at least moderate intervention self-efficacy, and d) provide pain outcomes data at 8 weeks.</measure>
    <time_frame>8 weeks</time_frame>
    <description>Number of randomized participants who: a) are retained at 8 weeks, b) attend at least 75% of intervention classes, c) demonstrate at least moderate intervention self-efficacy, and d) provide pain outcomes data at 8 weeks.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of screenees who are eventually randomized</measure>
    <time_frame>Randomization</time_frame>
    <description>Percentage of screenees who are eventually randomized</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of randomized participants who drop out by 8 weeks</measure>
    <time_frame>8 weeks</time_frame>
    <description>Percentage of randomized participants who drop out by 8 weeks</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of non-drop-outs completing at least 75% of intervention classes over 8 weeks</measure>
    <time_frame>8 weeks</time_frame>
    <description>Percentage of non-drop-outs completing at least 75% of intervention classes over 8 weeks</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of non-drop-outs completing at least 75% of home intervention practice over 8 weeks</measure>
    <time_frame>8 weeks</time_frame>
    <description>Percentage of non-drop-outs completing at least 75% of home intervention practice over 8 weeks</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of participants with at least moderate self-efficacy in performing postures/exercises at 8 weeks</measure>
    <time_frame>8 weeks</time_frame>
    <description>Participants will rate their self-confidence in performing each posture/exercise on a 5-point Likert scale (5-extremely, 4-very, 3-moderately, 2-somewhat, and 1-not at all confident. The percentage of participants with an average self-confidence score of 3 or higher across postures/exercises at 8 weeks will be calculated.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of participants rated by a consultant as being at least moderately competent in performing postures/exercises at 8 weeks</measure>
    <time_frame>8 weeks</time_frame>
    <description>Expert consultants will observe and rate participants' success in performing each posture/exercise on a 5-point Likert scale (5-extremely, 4-very, 3-moderately, 2-somewhat, and 1-not at all confident. The percentage of participants with an average competence rating of 3 or higher across postures/exercises at 8 weeks will be calculated.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of expected pain logs returned at 8 weeks</measure>
    <time_frame>8 weeks</time_frame>
    <description>Percentage of expected pain logs returned at 8 weeks</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of expected pain interference questionnaires returned at 8 weeks</measure>
    <time_frame>8 weeks</time_frame>
    <description>Percentage of expected pain interference questionnaires returned at 8 weeks</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of expected pelvic pain impact measures returned at 8 weeks</measure>
    <time_frame>8 weeks</time_frame>
    <description>Percentage of expected pelvic pain impact measures returned at 8 weeks</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">36</enrollment>
  <condition>Pelvic Pain</condition>
  <condition>Chronic Pelvic Pain</condition>
  <condition>Recurrent Pelvic Pain</condition>
  <arm_group>
    <arm_group_label>Yoga Program</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The study yoga intervention is designed to provide instruction and practice in selected yoga postures and techniques chosen by an expert panel for their potential to improve pelvic pain in women.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Physical Conditioning Program</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A low-impact, muscle stretching and strengthening program.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Yoga Program</intervention_name>
    <description>The yoga program is designed to maximize women's awareness of and control over the pelvic floor, promote relaxation, and improve physical function.</description>
    <arm_group_label>Yoga Program</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Physical Conditioning Program</intervention_name>
    <description>The physical conditioning program will focus on a core set of exercises designed to improve physical function and emotional well-being in order to improve management of chronic pain.</description>
    <arm_group_label>Physical Conditioning Program</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Women aged 18 years or older who report chronic or recurrent pelvic pain for at least&#xD;
             6 months&#xD;
&#xD;
          -  Report an average daily pain intensity score of at least 4 (on a 0 to 10 scale) on a&#xD;
             screening 7-day pain log&#xD;
&#xD;
          -  Report prior clinical evaluation of pain by a healthcare professional including at&#xD;
             least a superficial pelvic exam&#xD;
&#xD;
          -  Willing to refrain from initiating new clinical treatments that may affect their pain&#xD;
             during the study period&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Report pelvic pain occurring exclusively with menses or exclusively during sexual&#xD;
             intercourse (note that women with at least some pain between menses or intercourse are&#xD;
             still eligible)&#xD;
&#xD;
          -  Participation in organized yoga classes or muscle strengthening programs (e.g.,&#xD;
             Pilates) in the past month, or prior yoga therapy specifically directed a pelvic pain&#xD;
&#xD;
          -  Currently pregnant (by self-report or screening test), pregnant within the past 6&#xD;
             months, or planning pregnancy&#xD;
&#xD;
          -  Diagnosed with an alternate, reversible cause of pain that is unlikely to respond to&#xD;
             yoga and requires another treatment modality (e.g., current pelvic infection or a&#xD;
             gynecologic dermatosis)&#xD;
&#xD;
          -  Initiation, dose escalation, or weaning of pharmacologic agents that may affect pelvic&#xD;
             pain severity in the past 1 month (e.g., pain medications, antidepressants,&#xD;
             anticonvulsants)-note that women on stable doses will be eligible&#xD;
&#xD;
          -  Surgery to the genital or pelvic structures within 3 months, or prior cancer or&#xD;
             irradiation to these structures&#xD;
&#xD;
          -  Use of formal psychological therapies specifically for pelvic pain (e.g., systematic&#xD;
             desensitization, sex therapy, cognitive therapy, relaxation therapy) within 1 month of&#xD;
             screening&#xD;
&#xD;
          -  Use of formal behavioral therapies for pelvic or genital pain (e.g., pelvic floor&#xD;
             rehabilitation or biofeedback performed by a certified healthcare practitioner) within&#xD;
             1 month of screening&#xD;
&#xD;
          -  Unable to walk up a flight of stairs or at least 2 blocks on level ground (i.e.,&#xD;
             functional capacity &lt; 4 METs), or unable to get up from a supine to a standing&#xD;
             position without assistance&#xD;
&#xD;
          -  Participation in another interventional study that might interfere with or confound&#xD;
             study procedures&#xD;
&#xD;
          -  Known conflict with multiple available intervention class dates&#xD;
&#xD;
          -  Inability to sign an informed consent or fill out questionnaires or complete study&#xD;
             interviews in English, or lacking technical requirements to complete intervention&#xD;
             classes or study visits by video&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alison Huang, MD, MAS, MPhil</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Francisco</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alison Huang, MD, MAS, MPhil</last_name>
    <phone>415-514-8697</phone>
    <email>alison.huang@ucsf.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ann Chang</last_name>
    <phone>415-353-9782</phone>
    <email>ann.chang@ucsf.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of California, San Francisco</name>
      <address>
        <city>Oakland</city>
        <state>California</state>
        <zip>94612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Chatfield</last_name>
      <phone>415-885-7547</phone>
      <email>sarah.chatfield@ucsf.edu</email>
    </contact>
    <investigator>
      <last_name>Alison Huang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stanford University</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Kathryn Batham</last_name>
      <phone>650-724-7826</phone>
      <email>kbatham@stanford.edu</email>
    </contact>
    <investigator>
      <last_name>Leslee Subak, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California, San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94925</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Traci Plaut</last_name>
      <phone>415-885-7547</phone>
      <email>traci.plaut@ucsf.edu</email>
    </contact>
    <investigator>
      <last_name>Alison Huang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>October 28, 2020</study_first_submitted>
  <study_first_submitted_qc>October 28, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 4, 2020</study_first_posted>
  <last_update_submitted>March 31, 2021</last_update_submitted>
  <last_update_submitted_qc>March 31, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pelvic Pain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Starting no later than 6 months following publication of the main trial results (including on-line publication), the investigative team will make publically available de-identified individual participant data that underlie the results reported in the publication. This will include data about the baseline characteristics of the study participants and any primary or secondary trial outcomes presented in the publication.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_access_criteria>To gain access, data requestors will be asked to sign a data access agreement. In addition to signing a data access agreement, data requestors seeking to use trial data to generate new publications or presentations will be asked to submit a publication/presentation proposal that will be reviewed by the members of the trial steering committee, made up of the principal and co-investigators, for overlap with existing publication/presentation proposals as well as methodological appropriateness.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

